Handling Missing Data in Clinical Trials: An Overview

被引:0
|
作者
William R. Myers
机构
[1] Procter and Gamble Pharmaceuticals,Department of Biometrics and Statistical Sciences
[2] Procter and Gamble Pharmaceuticals,Department of Biometrics and Statistical Sciences
关键词
Clinical trials; Missing data; Dropouts; Imputation methods; Missing-data mechanism;
D O I
暂无
中图分类号
学科分类号
摘要
A major problem in the analysis of clinical trials is missing data caused by patients dropping out of the study before completion. This problem can result in biased treatment comparisons and also impact the overall statistical power of the study. This paper discusses some basic issues about missing data as well as potential “watch outs.” The topic of missing data is often not a major concern until it is time for data collection and data analysis. This paper provides potential design considerations that should be considered in order to mitigate patients from dropping out of a clinical study. In addition, the concept of the missing-data mechanism is discussed. Five general strategies of handling missing data are presented: I. Complete-case analysis, 2. “Weighting methods,” 3. Imputation methods, 4. Analyzing data as incomplete, and 5. “Other” methods. Within each strategy, several methods are presented along with advantages and disadvantages. Also briefly discussed is how the International Conference on Harmonization (ICH) addresses the issue of missing data. Finally, several of the methods that are illustrated in the paper are compared using a simulated data set.
引用
收藏
页码:525 / 533
页数:8
相关论文
共 50 条
  • [31] Handling missing data in longitudinal clinical trials: three examples from the pediatric psychology literature
    Peugh, James
    Mara, Constance
    JOURNAL OF PEDIATRIC PSYCHOLOGY, 2024,
  • [32] A SYSTEMATIC REVIEW ON REPORTING AND HANDLING OF MISSING DATA IN CARDIOVASCULAR TRIALS
    Malhotra, S.
    Gamad, N.
    Shafiq, N.
    JOURNAL OF HYPERTENSION, 2019, 37 : E90 - E90
  • [33] Methods for Missing Data Handling in Randomized Clinical Trials With Nonnormal Endpoints With Application to a Phase III Clinical Trial
    Fan, Chunpeng
    Zhang, Donghui
    Wei, Lynn
    Koch, Gary
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2016, 8 (02): : 179 - 193
  • [34] A LITERATURE REVIEW TO ASSESS METHODS FOR HANDLING MISSING DATA WITHIN THE HEALTH ECONOMIC EVALUATION OF CLINICAL TRIALS
    Garcia Sanchez, J. J.
    Darlington, O.
    Boyce, R.
    Ouwens, M.
    McEwan, P.
    Jackson, D.
    VALUE IN HEALTH, 2022, 25 (01) : S208 - S208
  • [35] Handling missing covariate data in clinical studies in haematology
    Bonneville, Edouard F.
    Schetelig, Johannes
    Putter, Hein
    de Wreede, Liesbeth C.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2023, 36 (02)
  • [36] Choosing estimands in clinical trials with missing data
    Mallinckrodt, Craig
    Molenberghs, Geert
    Rathmann, Suchitrita
    PHARMACEUTICAL STATISTICS, 2017, 16 (01) : 29 - 36
  • [37] Missing repeated measures data in clinical trials
    Pugh, Stephanie L.
    Brown, Paul D.
    Enserro, Danielle
    NEURO-ONCOLOGY PRACTICE, 2022, 9 (01) : 35 - 42
  • [38] Dealing With the Missing Data Challenge in Clinical Trials
    Permutt, Thomas
    Pinheiro, Jose
    DRUG INFORMATION JOURNAL, 2009, 43 (04): : 403 - 408
  • [39] Missing data in clinical trials for weight management
    McEvoy, Bradley W.
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2016, 26 (01) : 30 - 36
  • [40] The Prevention and Treatment of Missing Data in Clinical Trials
    Little, Roderick J.
    D'Agostino, Ralph
    Cohen, Michael L.
    Dickersin, Kay
    Emerson, Scott S.
    Farrar, John T.
    Frangakis, Constantine
    Hogan, Joseph W.
    Molenberghs, Geert
    Murphy, Susan A.
    Neaton, James D.
    Rotnitzky, Andrea
    Scharfstein, Daniel
    Shih, Weichung J.
    Siegel, Jay P.
    Stern, Hal
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (14): : 1355 - 1360